Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
0.00% | 3 | |
+7.65% | 113B | |
+10.96% | 106B | |
+0.41% | 22.27B | |
-11.98% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.83% | 17.24B | |
+7.01% | 14.29B | |
+35.27% | 12.52B |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- Transcript : Nabriva Therapeutics plc, Q2 2022 Earnings Call, Aug 03, 2022